ATE33556T1 - Adenosinderivate enthaltende pharmazeutische zusammensetzung fuer behandlung von tumoren. - Google Patents
Adenosinderivate enthaltende pharmazeutische zusammensetzung fuer behandlung von tumoren.Info
- Publication number
- ATE33556T1 ATE33556T1 AT83106808T AT83106808T ATE33556T1 AT E33556 T1 ATE33556 T1 AT E33556T1 AT 83106808 T AT83106808 T AT 83106808T AT 83106808 T AT83106808 T AT 83106808T AT E33556 T1 ATE33556 T1 AT E33556T1
- Authority
- AT
- Austria
- Prior art keywords
- adenosine
- cells
- tumor cells
- adp
- atp
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
- C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/397,897 US4880918A (en) | 1982-07-13 | 1982-07-13 | Arrest and killing of tumor cells by adenosine 5-diphosphate and adenosine-5-triphosphate |
EP83106808A EP0100022B1 (de) | 1982-07-13 | 1983-07-11 | Adenosinderivate enthaltende pharmazeutische Zusammensetzung für Behandlung von Tumoren |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE33556T1 true ATE33556T1 (de) | 1988-05-15 |
Family
ID=23573118
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT83106808T ATE33556T1 (de) | 1982-07-13 | 1983-07-11 | Adenosinderivate enthaltende pharmazeutische zusammensetzung fuer behandlung von tumoren. |
Country Status (5)
Country | Link |
---|---|
US (1) | US4880918A (de) |
EP (1) | EP0100022B1 (de) |
JP (1) | JPS5921618A (de) |
AT (1) | ATE33556T1 (de) |
DE (1) | DE3376295D1 (de) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1223831A (en) | 1982-06-23 | 1987-07-07 | Dean Engelhardt | Modified nucleotides, methods of preparing and utilizing and compositions containing the same |
US7220854B1 (en) | 1982-06-23 | 2007-05-22 | Enzo Life Sciences, Inc. C/O Enzo Biochem, Inc. | Sugar moiety labeled nucleotide, and an oligo- or polynucleotide, and other compositions comprising such sugar moiety labeled nucleotides |
US5227371A (en) * | 1982-07-13 | 1993-07-13 | Eliezer Rapaport | Utilization of adenine nucleotides and/or adenosine and inorganic phosphate for elevation of liver, blood and blood plasma adenosine 5'-triphosphate concentrations |
US5049372A (en) * | 1982-07-13 | 1991-09-17 | Eliezer Rapaport | Anticancer activities in a host by increasing blood and plasma adenosine 5'-triphosphate (ATP) levels |
JPS5925325A (ja) * | 1982-07-30 | 1984-02-09 | Taiho Yakuhin Kogyo Kk | 癌治療剤 |
IT1162938B (it) * | 1983-08-26 | 1987-04-01 | Dino Spisni | Composizione per la cura dei tumori maligni in particolare sugli animali |
JPS6240252A (ja) * | 1985-08-19 | 1987-02-21 | Sakuma Kenji | フライ食品の製造方法および装置 |
US5679650A (en) * | 1993-11-24 | 1997-10-21 | Fukunaga; Atsuo F. | Pharmaceutical compositions including mixtures of an adenosine compound and a catecholamine |
US6180616B1 (en) | 1990-05-10 | 2001-01-30 | Atsuo F. Fukunaga | Use of purine receptor agonists to alleviate or normalize physiopathologically excited sensory nerve function |
US5677290A (en) * | 1990-05-10 | 1997-10-14 | Fukunaga; Atsuo F. | Therapeutic use of adenosine compounds as surgical anesthetics |
US6004945A (en) * | 1990-05-10 | 1999-12-21 | Fukunaga; Atsuo F. | Use of adenosine compounds to relieve pain |
US7671038B1 (en) * | 1993-10-08 | 2010-03-02 | Eliezer Rapaport | Method of therapeautic treatments including human immunodeficiency virus (HIV) disease and other conditions in a human host by administering adenine nucleotides |
HU213677B (en) * | 1993-11-09 | 1997-12-29 | Immunal Kft | Pharmaceutical compositions for preventing and treating tumor diseases, and process for producing them |
US6159701A (en) * | 1996-11-08 | 2000-12-12 | Link Technology Incorporated | Method and compositions for treating and diagnosing tumors using adenosine receptor activated cells |
US20030008369A1 (en) * | 1999-03-03 | 2003-01-09 | Board Of Regents, The University Of Texas System | Genetic and epigenetic manipulation of ABC transporters and ecto-phosphatases |
US6579857B1 (en) * | 1999-06-11 | 2003-06-17 | Evanston Northwestern Healthcare Research Institute | Combination cancer therapy comprising adenosine and deaminase enzyme inhibitors |
US6680052B1 (en) | 1999-11-08 | 2004-01-20 | Endacea, Inc. | Methods of inhibiting tumor growth using adenosine receptor activated cells |
US7629329B2 (en) * | 2001-06-04 | 2009-12-08 | Tsi Health Sciences, Inc. | Method for increasing muscle mass and strength through administration of adenosine triphosphate |
WO2003061568A2 (en) * | 2002-01-16 | 2003-07-31 | Eliezer Rapaport | Methods and therapeutic compositions in the treatment of advanced cancer |
US7148210B2 (en) * | 2002-10-15 | 2006-12-12 | Trustees Of Dartmouth College | Method of treating bone metastasis |
CA3010140C (en) | 2015-12-29 | 2021-05-11 | Marc Purcell | Composition for energy supplementation |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4396609A (en) * | 1975-02-18 | 1983-08-02 | Sterling Drug Inc. | Aminocyclitol antibiotics, pharmaceutical compositions and method of using same |
JPS5634697A (en) * | 1979-08-31 | 1981-04-06 | Wakunaga Yakuhin Kk | Preparation of 5'-triphosphoryladnylyl-(2'-5')-adenylyl-(2'-5')-adenosine |
-
1982
- 1982-07-13 US US06/397,897 patent/US4880918A/en not_active Expired - Lifetime
-
1983
- 1983-07-08 JP JP58125355A patent/JPS5921618A/ja active Granted
- 1983-07-11 AT AT83106808T patent/ATE33556T1/de not_active IP Right Cessation
- 1983-07-11 DE DE8383106808T patent/DE3376295D1/de not_active Expired
- 1983-07-11 EP EP83106808A patent/EP0100022B1/de not_active Expired
Also Published As
Publication number | Publication date |
---|---|
EP0100022B1 (de) | 1988-04-20 |
JPS5921618A (ja) | 1984-02-03 |
US4880918A (en) | 1989-11-14 |
DE3376295D1 (en) | 1988-05-26 |
JPS637527B2 (de) | 1988-02-17 |
EP0100022A1 (de) | 1984-02-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE33556T1 (de) | Adenosinderivate enthaltende pharmazeutische zusammensetzung fuer behandlung von tumoren. | |
ES2067508T3 (es) | Dihidroisoquinolinonas sustituidas y compuestos relacionados como potenciadores de los efectos letales de la radiacion y de ciertos agentes quimioterapeuticos; compuestos seleccionados, analogos y proceso. | |
ATE13487T1 (de) | Arzneimittelformulierung zur oralen verabreichung mit gehalt an einem polaren bioaktiven wirkstoff und einem hilfsstoff. | |
SE8402550L (sv) | N-substituerade deridvat av moranolin | |
DK471085D0 (da) | Farmaceutiske sammensaetninger indeholdende syntetiske phospholipiderog et farmaceutisk aktivt stof samt deres fremstilling og anvendelse | |
MX168494B (es) | Nuevos derivados de pirazolina su preparacion y su uso como plaguisidas | |
DK474688A (da) | Praeparat til bekaempelse af tumor eller kraeftceller | |
DE58901002D1 (de) | Mittel mit zerstoerender wirkung auf maligne tumore, verfahren zu dessen herstellung und praeparation zur anwendung in der therapie von krebskranken. | |
SE7902742L (sv) | Disubstituerade 3-cefem-4-karboxylsyraderivat samt forfarande for framstellning derav | |
SE8303003D0 (sv) | Medel for att oka antitumorverkan hos antitumormedel | |
FI813912L (fi) | I laekemedel anvaendbara tricykliska cytosinderivat och foerfarande foer deras framstaellning | |
ATE43967T1 (de) | Antitumorale arzneimittel und verbindungen fuer behandlung von tumoren unter anwendung von (alpha, omega-bis(disubstituierte phosphino) kohlenwasserstoff> digold (i), digold (iii), disilber (i) und dikupfer (i)-derivaten. | |
Reuvers et al. | Potential use of nitrofurans in radiotherapy | |
DE3484904D1 (de) | Arzneimittelzusammensetzungen ermaessigter toxizitaet. | |
ES2043696T3 (es) | Derivados de prostaglandina e1 (derivados-pge1) como substancias activas farmaceuticas y medicamentos que contienen estos compuestos, especialmente para aplicacion transcutanea. | |
NO172537C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive 3-desmetyl-4-fluor-mevalonsyrederivater | |
SE8700555L (sv) | Purinderivat, deras framstellning och lekemedel innehallande dessa | |
IE45054L (en) | Veterinary composition | |
Campbell et al. | Effect of environmental temperature on the metabolic response to injury | |
DE3781483D1 (de) | Pharmazeutische zusammensetzung zum schutz von gehirnzellen. | |
DE3883044D1 (de) | Wirkstoff zur tumorbekaempfung. | |
BIRKMAYER et al. | Evidence for proflavine sensitive proteins in malignant hamster melanoma | |
ATE126437T1 (de) | Verwendung von depogen zur behandlung von eingeschränktem blutkreislauf. | |
DK524185D0 (da) | Pyrazindiazohydroxidforbindelser og fremgangsmaader til deres fremstilling og anvendelse | |
Montecuccoli et al. | Inhibition by α-amanitin of chromosomal ribonucleic acid synthesis in rat liver |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification | ||
REN | Ceased due to non-payment of the annual fee |